Pharmaceutical Market Forecast Revised Downwards

BMI View: While Indonesia's pharmaceutical market is small compared with many of its Asia Pacific neighbours, BMI believes that robust expenditure growth, combined with rising population numbers and a relatively solid political and economic base, will continue to provide substantial income to companies operating in the country, encouraging multinationals to invest there.

To read the full article, please choose one of the following options: